Stocks and Investing
Stocks and Investing
Fri, May 3, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Scott Fidel Maintained (ALHC) at Hold with Increased Target to $7 on, May 3rd, 2024
Scott Fidel of Stephens & Co., Maintained "Alignment Healthcare, Inc." (ALHC) at Hold with Increased Target from $6 to $7 on, May 3rd, 2024.
Scott has made no other calls on ALHC in the last 4 months.
There are 5 other peers that have a rating on ALHC. Out of the 5 peers that are also analyzing ALHC, 2 agree with Scott's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Jessica Tassan of "Piper Sandler" Downgraded from Buy to Hold and Decreased Target to $6 on, Wednesday, March 6th, 2024
- Kevin Caliendo of "UBS" Maintained at Hold with Decreased Target to $8.5 on, Wednesday, February 28th, 2024
These are the ratings of the 3 analyists that currently disagree with Scott
- Craig Jones of "Stifel" Maintained at Strong Buy with Decreased Target to $9 on, Tuesday, April 23rd, 2024
- Andrew Mok of "Barclays" Initiated at Sell and Held Target at $4.5 on, Wednesday, March 6th, 2024
- John Ransom of "Raymond James" Maintained at Strong Buy with Increased Target to $12 on, Tuesday, January 9th, 2024
Contributing Sources